Raymond Cohen Buys Shares of RXST $RXST

Editorial illustration for RxSight, Inc. (RXST)

Key Points

  • Raymond Cohen bought 30,864 shares of RxSight, Inc. ($RXST).
  • $RXST last traded around $4.73.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Raymond Cohen, insider at RxSight, Inc. ($RXST), bought 30,864 shares. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.

RxSight, Inc. Stock Down 32.9%

Shares of RxSight, Inc. ($RXST) traded around $4.73 on Thursday, down 32.9% for the day.

Last price$4.73
Market cap$304.88M
Forward P/E-10.52
Beta1.13
52-week low$4.48
52-week high$13.22
50-day MA$5.87
200-day MA$7.62
Current ratio4.07
Quick ratio3.57
Debt-to-equity0.04

RxSight, Inc. Earnings

EPS (ttm)-$1.14
Revenue (ttm)$127.58M
Revenue growth0.30%
Net margin-36.80%
Return on equity-17.34%
Next earningsNov 4, 2026

Analysts Set New Price Targets

Average target$7.79
High target$11
Low target$6
Analysts covering8

About RxSight, Inc.

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.

ExchangeNasdaqGM
SectorHealthcare
IndustryMedical Devices
HeadquartersAliso Viejo, CA
CEOMr. Aziz Mottiwala M.B.A.
Employees461

Get RxSight, Inc. alerts

New 13F filings, insider trades, and analyst moves on $RXST, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.